Trial Outcomes & Findings for Detachable String Magnetically Controlled Capsule Endoscopy for Completely Viewing of Esophagus and Stomach (NCT NCT03457909)
NCT ID: NCT03457909
Last Updated: 2019-09-23
Results Overview
evaluate the feasibility of the novel DS-MCE examination. The successful separation of the capsule and string was evaluated by the capsule entering the stomach and and the string being pulled out.Complete viewing of esophagus and stomach was evaluated by completing the procedure from the capsule being swallowed, the esophagus observed retrograde, to the string being pulled out after separating from the capsule.This primary outcome indicated how many participatns completed the DS-MCE examination successfully.
COMPLETED
NA
25 participants
up to 2 weeks
2019-09-23
Participant Flow
Healthy volunteers or patients with suspected esophageal diseases were prospectively enrolled in Changhai Hospital from March 2018 to June 2018.
This study was a prospective, self-controlled, single-centered pilot study. After enrollment, each enrolled subject first underwent DS-MCE(detachable string magnetically controlled capsule endoscopy), and subsequently EGD(esophagogastroduodenoscopy) within one week.
Participant milestones
| Measure |
DS-MCE
outpatients who have esophagus symptoms will take DS-MCE and conventional endoscopy examination examination.
DS-MCE: During the DS-MCE examination,the capsule is allowed to travel down into gastric cardia,from where the string is slowly pulled to allow the capsule to view the esophagus retrogradely.
|
|---|---|
|
Overall Study
STARTED
|
25
|
|
Overall Study
COMPLETED
|
25
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
DS-MCE
n=25 Participants
outpatients who have esophagus symptoms will take DS-MCE and conventional endoscopy examination examination successively.
DS-MCE: During the DS-MCE examination,the capsule is allowed to travel down into gastric cardia,from where the string is slowly pulled to allow the capsule to view the esophagus retrogradely.
|
|---|---|
|
Age, Continuous
|
54 years
n=25 Participants
|
|
Sex: Female, Male
Female
|
7 Participants
n=25 Participants
|
|
Sex: Female, Male
Male
|
18 Participants
n=25 Participants
|
|
Region of Enrollment
China
|
25 participants
n=25 Participants
|
PRIMARY outcome
Timeframe: up to 2 weeksevaluate the feasibility of the novel DS-MCE examination. The successful separation of the capsule and string was evaluated by the capsule entering the stomach and and the string being pulled out.Complete viewing of esophagus and stomach was evaluated by completing the procedure from the capsule being swallowed, the esophagus observed retrograde, to the string being pulled out after separating from the capsule.This primary outcome indicated how many participatns completed the DS-MCE examination successfully.
Outcome measures
| Measure |
DS-MCE
n=25 Participants
outpatients who have esophagus symptoms will take DS-MCE and conventional endoscopy examination examination.
DS-MCE: During the DS-MCE examination,the capsule is allowed to travel down into gastric cardia,from where the string is slowly pulled to allow the capsule to view the esophagus retrogradely.
|
|---|---|
|
Number of Participants With Successful Separation of Capsule and String, and Complete Viewing of Esophagus and Stomach
|
25 Participants
|
SECONDARY outcome
Timeframe: up to 2 weeksevaluate the safety of DS-MCE.Record any adverse event during the procedure and after the procedure.Patients will be followed up by telephone to inquire about the symptoms of abdominal distention, abdominal pain,vomiting and other discomfort. Follow up to the end of the capsule expulsion.
Outcome measures
| Measure |
DS-MCE
n=25 Participants
outpatients who have esophagus symptoms will take DS-MCE and conventional endoscopy examination examination.
DS-MCE: During the DS-MCE examination,the capsule is allowed to travel down into gastric cardia,from where the string is slowly pulled to allow the capsule to view the esophagus retrogradely.
|
|---|---|
|
Number of DS-MCE Associated Adverse Events
|
0 adverse events
|
SECONDARY outcome
Timeframe: up to 2 weekstime from the capsule swallowed to the capsule entering the gastric cardia to examine the stomach
Outcome measures
| Measure |
DS-MCE
n=25 Participants
outpatients who have esophagus symptoms will take DS-MCE and conventional endoscopy examination examination.
DS-MCE: During the DS-MCE examination,the capsule is allowed to travel down into gastric cardia,from where the string is slowly pulled to allow the capsule to view the esophagus retrogradely.
|
|---|---|
|
Duration of Time Capsule is Within the Esophagus
|
6.2 minutes
Interval 2.2 to 22.2
|
SECONDARY outcome
Timeframe: up to 2 weeksZ-line represents the normal esophagogastric junction where the squamous mucosa of the esophagus and columnar mucosa of the stomach meet.We can devide the Z-line into four quadrants under capsule endoscopy. Observing all the four quadrants is considered to be a complete observation of Z-line. In this study,the number of participants with at least two quadrants of Z-line visualized was used to evaluate the Z-line visulization.
Outcome measures
| Measure |
DS-MCE
n=25 Participants
outpatients who have esophagus symptoms will take DS-MCE and conventional endoscopy examination examination.
DS-MCE: During the DS-MCE examination,the capsule is allowed to travel down into gastric cardia,from where the string is slowly pulled to allow the capsule to view the esophagus retrogradely.
|
|---|---|
|
Z-line Visualization
|
20 participants
|
SECONDARY outcome
Timeframe: up to 2 weeksgrade (mild, moderate,and severe) of air-bubble and saliva interference on the Z-line view(0, no intraluminal gas bubble; 1, a few gas bubbles, no limitation of interpretation; 2, an increased amount of intraluminal foam/gas bubbles, moderate limitation of visibility; 3, an amount of foam/gas bubbles)
Outcome measures
| Measure |
DS-MCE
n=25 Participants
outpatients who have esophagus symptoms will take DS-MCE and conventional endoscopy examination examination.
DS-MCE: During the DS-MCE examination,the capsule is allowed to travel down into gastric cardia,from where the string is slowly pulled to allow the capsule to view the esophagus retrogradely.
|
|---|---|
|
Quality Score of Z-line Images
|
0.68 score on a scale
Interval 0.0 to 1.0
|
SECONDARY outcome
Timeframe: up to 2 weeksevaluate patient's degree of comfort throughout the procedure.Patients will be asked to fill in a questionnaire to give scores about degree of comfort throughout the procedure.Overall discomfort was scored on a scale of 0 to 10 (0, no discomfort; 10, the overall discomfort of EGD).
Outcome measures
| Measure |
DS-MCE
n=25 Participants
outpatients who have esophagus symptoms will take DS-MCE and conventional endoscopy examination examination.
DS-MCE: During the DS-MCE examination,the capsule is allowed to travel down into gastric cardia,from where the string is slowly pulled to allow the capsule to view the esophagus retrogradely.
|
|---|---|
|
Degree of Comfort
|
0.96 score on a scale
Interval 0.0 to 3.0
|
Adverse Events
DS-MCE
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place